APA

Schittenhelm M. M., Yee K. W. H., Tyner J. W., McGreevey L., Haley A. D., Town A., Griffith D. J., Bainbridge T., Braziel R. M., O'Farrell A., Cherrington J. M. & Heinrich M. C. (20061205). FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248). : Leukemia.

Chicago

Schittenhelm M M, Yee K W H, Tyner J W, McGreevey L, Haley A D, Town A, Griffith D J, Bainbridge T, Braziel R M, O'Farrell A-M, Cherrington J M and Heinrich M C. 20061205. FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248). : Leukemia.

Harvard

Schittenhelm M. M., Yee K. W. H., Tyner J. W., McGreevey L., Haley A. D., Town A., Griffith D. J., Bainbridge T., Braziel R. M., O'Farrell A., Cherrington J. M. and Heinrich M. C. (20061205). FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248). : Leukemia.

MLA

Schittenhelm M M, Yee K W H, Tyner J W, McGreevey L, Haley A D, Town A, Griffith D J, Bainbridge T, Braziel R M, O'Farrell A-M, Cherrington J M and Heinrich M C. FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248). : Leukemia. 20061205.